Acumen Pharmaceuticals, Inc. Quarterly Marketable Securities, Current in USD from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Acumen Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q3 2021 to Q2 2024.
  • Acumen Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $193M, a 185% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $193M +$125M +185% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $206M +$143M +229% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $177M +$129M +272% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $121M +$77.9M +183% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $67.6M -$11.2M -14.2% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $62.4M -$17.9M -22.3% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $47.5M -$24.6M -34.1% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $42.7M -$21.5M -33.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $78.8M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $80.3M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $72.1M Dec 31, 2021 10-K 2023-03-27
Q3 2021 $64.2M Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.